0001555280-22-000221.txt : 20220726 0001555280-22-000221.hdr.sgml : 20220726 20220726163641 ACCESSION NUMBER: 0001555280-22-000221 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220722 FILED AS OF DATE: 20220726 DATE AS OF CHANGE: 20220726 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lagano Roxanne CENTRAL INDEX KEY: 0001567878 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 221107538 MAIL ADDRESS: STREET 1: C/O ZOETIS INC. STREET 2: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460696167 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 wf-form4_165886778126391.xml FORM 4 X0306 4 2022-07-22 0 0001555280 Zoetis Inc. ZTS 0001567878 Lagano Roxanne C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054 0 1 0 0 Executive Vice President Common Stock 2022-07-22 4 M 0 1163 73.24 A 24850 D Common Stock 2022-07-22 4 M 0 1004 87.51 A 25854 D Common Stock 2022-07-22 4 S 0 2167 180.26 D 23687 D Stock Option 2022-07-22 4 M 0 1163 0 D Common Stock 1163.0 38573 D Stock Option 2022-07-22 4 M 0 1004 0 D Common Stock 1004.0 37569 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2022. The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. 1,163 options granted February 13, 2018 at an exercise price of $73.24 per option. Each option vests on the third anniversary of the date of grant. Each option expires on the tenth anniversary of the date of grant. 9,312 options granted February 13, 2018 at an exercise price of $73.24 per option; 9,040 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. 1,004 options granted February 12, 2019 at an exercise price of $87.51 per option. 9,312 options granted February 13, 2018 at an exercise price of $73.24 per option; 8,036 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. /s/ Brenda Santuccio, as Attorney-in-Fact 2022-07-26